Since our treatment-naïve CVID patients were characterized by low Acrp30 concentrations (Table 2), we hypothesize that Ig administration modulates the activation state and the cytokine profile involved in the chronic immune activation signature of CVID. Here, ADIPOQ is linked to common variable immunodeficiency.